63P Treatment-free survival (TFS) in patients (pts) with mNSCLC treated with 1L nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) vs chemo alone (4 cycles) in CheckMate (CM) 9LA

Saved in:
Bibliographic Details
Published in:ESMO open 2024-03, Vol.9, p.102642, Article 102642
Main Authors: Reck, M., Regan, M., Carbone, D.P., Lu, S., John, T., Penrod, J., Li, J., Yuan, Y., Mahmood, J., Lee, A., Eccles, L., Ray, S., Paz-Ares, L.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2024.102642